variables: 815286
Data license: CC-BY
This data as json
id | name | unit | description | createdAt | updatedAt | code | coverage | timespan | datasetId | sourceId | shortUnit | display | columnOrder | originalMetadata | grapherConfigAdmin | shortName | catalogPath | dimensions | schemaVersion | processingLevel | processingLog | titlePublic | titleVariant | attributionShort | attribution | descriptionShort | descriptionFromProducer | descriptionKey | descriptionProcessing | licenses | license | grapherConfigETL | type | sort | dataChecksum | metadataChecksum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
815286 | Statin use for secondary prevention amongst elibible individuals | % | 2023-10-10 15:55:35 | 2024-07-08 17:24:04 | 2019-2019 | 6266 | % | { "unit": "%", "shortUnit": "%", "numDecimalPlaces": 1 } |
0 | statin_use_secondary | grapher/statins/2023-10-05/lancet_2022/lancet_2022#statin_use_secondary | 2 | minor | Proportion of eligible individuals self-reporting use of statins for the secondary prevention of cardiovascular disease | Eligibility for statin therapy for secondary prevention was defined among individuals with a history of self-reported cardiovascular disease. | [] |
float | [] |
ded684a717cb9dd22217ad0c692b52fa | d13901ec727f3955d6d5677d51b62df5 |